These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26032092)

  • 1. Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation.
    Guo H; Xu Y; Fu Q
    Tumour Biol; 2015 Nov; 36(11):8511-7. PubMed ID: 26032092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rh2 inhibits prostate cancer cell growth through suppression of microRNA-4295 that activates CDKN1A.
    Gao Q; Zheng J
    Cell Prolif; 2018 Jun; 51(3):e12438. PubMed ID: 29457293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
    Li S; Wang C; Yu X; Wu H; Hu J; Wang S; Ye Z
    Oncol Rep; 2017 Jan; 37(1):241-248. PubMed ID: 27878260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.
    Lei ST; Shen F; Chen JW; Feng JH; Cai WS; Shen L; Hu ZW; Xu B
    Biomed Pharmacother; 2016 Dec; 84():1834-1840. PubMed ID: 27829546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
    Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
    J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGF.
    Zeng Y; Shen Z; Gu W; Wu M
    Gene; 2018 Apr; 651():183-193. PubMed ID: 29408622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
    Wu Z; He B; He J; Mao X
    Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells.
    Zhu M; Zheng Z; Huang J; Ma X; Huang C; Wu R; Li X; Liang Z; Deng F; Wu J; Geng S; Xie C; Zhong C
    J Cell Biochem; 2019 Sep; 120(9):15616-15624. PubMed ID: 31042325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A.
    Brock M; Haider TJ; Vogel J; Gassmann M; Speich R; Trenkmann M; Ulrich S; Kohler M; Huber LC
    Int J Biochem Cell Biol; 2015 Apr; 61():129-37. PubMed ID: 25681685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
    Deng G; Yu JH; Ye ZQ; Hu ZQ
    Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma.
    Gibcus JH; Kroesen BJ; Koster R; Halsema N; de Jong D; de Jong S; Poppema S; Kluiver J; Diepstra A; van den Berg A
    J Pathol; 2011 Dec; 225(4):609-17. PubMed ID: 21953646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
    J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.
    Jiang L; Huang J; Li L; Chen Y; Chen X; Zhao X; Yang D
    J Clin Endocrinol Metab; 2015 May; 100(5):E729-38. PubMed ID: 25695884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: MicroRNA cell specific induction of CDKN1A (p21) as a common mechanism involved.
    González-Sarrías A; Núñez-Sánchez MÁ; Tomé-Carneiro J; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Mol Nutr Food Res; 2016 Apr; 60(4):701-16. PubMed ID: 26634414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.
    Xu L; Zhong J; Guo B; Zhu Q; Liang H; Wen N; Yun W; Zhang L
    Tumour Biol; 2016 Sep; 37(9):12023-12032. PubMed ID: 27164937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway.
    Teiten MH; Gaascht F; Cronauer M; Henry E; Dicato M; Diederich M
    Int J Oncol; 2011 Mar; 38(3):603-11. PubMed ID: 21240460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.
    Han G; Fan M; Zhang X
    Biochem Biophys Res Commun; 2015 Jan; 456(3):804-9. PubMed ID: 25511701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits oral squamous cell carcinoma SCC-9 cells proliferation by regulating miR-9 expression.
    Xiao C; Wang L; Zhu L; Zhang C; Zhou J
    Biochem Biophys Res Commun; 2014 Nov; 454(4):576-80. PubMed ID: 25450696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway.
    Yang ZP; Zhao Y; Huang F; Chen J; Yao YH; Li J; Wu XN
    World J Gastroenterol; 2015 Sep; 21(36):10385-99. PubMed ID: 26420965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.